Minerva surgical reports preliminary fourth quarter and full year 2021 revenue

Santa clara, calif., jan. 11, 2022 (globe newswire) -- minerva surgical, inc. (nasdaq: utrs) (minerva surgical or the company), a medical device company that has established a broad product line of commercially available, minimally invasive medical devices that address the most common causes of abnormal uterine bleeding (aub) as alternatives to hysterectomy, today reported preliminary unaudited fourth quarter and full year 2021 revenue expectations.
UTRS Ratings Summary
UTRS Quant Ranking